Update Venetoclax in CLL
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
NCCN Guidelines for Patients
ASH: COVID-19 Resources for Managing Blood Cancers
CLL Society
UpToDate